BAJAJ BROKING

Notification
No new Notification messages
Senores Pharmaceuticals IPO is Open!
Apply for the Senores Pharmaceuticals IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

Colgate-Palmolive India Q2 Results FY24-25: Revenue Hits ₹1,609.21 Cr, PAT Jumps to ₹395.1 Cr

Listen to our Podcast: Grow your wealth and keep it secure.

0:00 / 0:00

Synopsis:

Colgate-Palmolive India reported a 10% revenue growth in Q2 FY24-25, reaching ₹1,609.2 crore. The net profit after tax (PAT) grew by 16.2%, amounting to ₹395.1 crore. Discover the detailed financial performance and key highlights here.

Key Highlights

  • Revenue Growth: Colgate-Palmolive India achieved a 10% YoY growth in revenue, reaching ₹1,609.2 crore in Q2 FY24-25, driven by strong domestic performance.
  • PAT Growth: Net profit after tax surged 16.2% YoY to ₹395.1 crore.
  • Interim Dividend: Declared a first interim dividend of ₹24 per share, aggregating to ₹653 crore.

COLGATE PALMOLIVE LTD.

Trade

27314.30 (0.15 %)

Updated - 24 December 2024
2737.55day high
DAY HIGH
2722.00day low
DAY LOW
280672
VOLUME (BSE)

Quarterly Performance - Colgate-Palmolive India Q2 Results FY24-25

Particulars

Q2 FY25 (₹ Lakhs)

Q2 FY24 (₹ Lakhs)

YoY Change (%)

Revenue from Operations

160921

146238

10.0

Total Income

169509

149210

13.6

Total Expenses

116464

103429

12.6

Profit Before Tax

53045

45781

15.8

Profit After Tax (PAT)

39505

34005

16.2

In terms of profitability, the company posted a net profit of ₹395.1 crore, an increase of 16.2% YoY. This improvement in profitability was partially driven by a one-off credit related to interest on income tax refunds.

Segment Highlights

  • Oral Care Segment: The Oral Care segment remains the core contributor to the company's revenue growth. Products such as Colgate Maxfresh and Colgate Strong Teeth recorded high volume growth.
  • Personal Care Segment: Colgate’s other personal care offerings also contributed to the growth, with increasing demand for products under its Colgate Total brand.

Sector Expectations for Colgate-Palmolive Q2 Results FY24-25

Colgate-Palmolive India’s Q2 performance aligns well with sector expectations, especially with strong sales in oral care. The company’s focus on premiumisation and new product launches like Colgate Visible White Purple helped maintain competitive positioning in a challenging market environment.

Management Commentary

Prabha Narasimhan, Managing Director & CEO of Colgate-Palmolive India, expressed satisfaction with the company’s robust performance despite a tough operating environment. She highlighted that core brands performed well, and new innovations like Colgate Visible White Purple were met with a positive market response. Moving forward, Colgate remains committed to investing in superior products and strong marketing to sustain growth.

Check out Colgate Palmolive's past performances in previous quarters and financial years.

Disclaimer: Investments in the securities market are subject to market risk, read all related documents carefully before investing.

This content is for educational purposes only. Securities quoted are exemplary and not recommendatory.

For All Disclaimers Click Here: https://bit.ly/3Tcsfuc

Share this article: 

Read More Blogs

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text